{"transactions":[{"id":4613214,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-09-09T18:35:46.000Z","date":"2026-09-07","kind":"exercise","planned":false,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001437749-26-029963","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1821479/000143774926029963/rdgdoc.xml","form_type":"4"}},{"id":4613213,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-09-09T18:35:46.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":1519,"price":42.54,"value":64618.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":53141,"source":{"system":"sec-edgar","filing":"0001437749-26-029963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1821479/000143774926029963/rdgdoc.xml","form_type":"4"}},{"id":4613212,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-09-09T18:35:46.000Z","date":"2026-09-07","kind":"exercise","planned":false,"acquired":true,"shares":3334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":54660,"source":{"system":"sec-edgar","filing":"0001437749-26-029963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1821479/000143774926029963/rdgdoc.xml","form_type":"4"}},{"id":909928,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":32609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029."}],"balance_after":32609,"derivative":{"underlying":"Ordinary Shares","underlying_shares":32609},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909927,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909926,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026."}],"balance_after":6667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909925,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."}],"balance_after":5500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909924,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":3217,"price":19.69,"value":63342.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":55588,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909923,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":49972,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909922,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":1608,"price":19.69,"value":31661.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":51326,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909921,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":58805,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909920,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":2654,"price":19.69,"value":52257.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":52934,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":909919,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2026-02-11T19:54:58.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":55472,"source":{"system":"sec-edgar","filing":"0001437749-26-003778","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774926003778/rdgdoc.xml","form_type":"4"}},{"id":1044771,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-09-09T22:32:09.000Z","date":"2025-09-07","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":3334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-25-028705","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925028705/rdgdoc.xml","form_type":"4"}},{"id":1044770,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-09-09T22:32:09.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":1520,"price":19.11,"value":29047.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":43305,"source":{"system":"sec-edgar","filing":"0001437749-25-028705","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925028705/rdgdoc.xml","form_type":"4"}},{"id":1044769,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-09-09T22:32:09.000Z","date":"2025-09-07","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":44825,"source":{"system":"sec-edgar","filing":"0001437749-25-028705","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925028705/rdgdoc.xml","form_type":"4"}},{"id":1079097,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:03:45.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":7522,"price":19.14,"value":143971.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of performance stock units."}],"balance_after":41492,"source":{"system":"sec-edgar","filing":"0001437749-25-023963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925023963/rdgdoc.xml","form_type":"4"}},{"id":1079096,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-07-30T20:03:45.000Z","date":"2025-07-28","kind":"exercise","planned":false,"acquired":true,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the settlement of performance stock units granted on January 31, 2024 that vested upon the achievement of a corporate milestone event."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":49014,"source":{"system":"sec-edgar","filing":"0001437749-25-023963","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925023963/rdgdoc.xml","form_type":"4"}},{"id":1284830,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028."}],"balance_after":10000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284829,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025."}],"balance_after":11000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284828,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."}],"balance_after":6667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284827,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284826,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"sale","planned":false,"acquired":false,"shares":2767,"price":11.14,"value":30824.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":32514,"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284825,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":35281,"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284824,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"sale","planned":false,"acquired":false,"shares":3354,"price":11.14,"value":37363.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":29781,"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284823,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":33135,"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284822,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"sale","planned":false,"acquired":false,"shares":1258,"price":11.14,"value":14014.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":26468,"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1284821,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2025-02-04T16:51:51.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":27726,"source":{"system":"sec-edgar","filing":"0001437749-25-002685","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774925002685/rdgdoc.xml","form_type":"4"}},{"id":1408658,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-09-12T17:51:58.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024."}],"balance_after":6667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001437749-24-029038","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924029038/rdgdoc.xml","form_type":"4"}},{"id":1408657,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-09-12T17:51:58.000Z","date":"2024-09-09","kind":"sale","planned":false,"acquired":false,"shares":1521,"price":13.08,"value":19894.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":25226,"source":{"system":"sec-edgar","filing":"0001437749-24-029038","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924029038/rdgdoc.xml","form_type":"4"}},{"id":1408656,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-09-12T17:51:58.000Z","date":"2024-09-09","kind":"exercise","planned":false,"acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":26747,"source":{"system":"sec-edgar","filing":"0001437749-24-029038","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924029038/rdgdoc.xml","form_type":"4"}},{"id":1658917,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-06T02:16:49.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":3328,"price":15.78,"value":52515.84,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024."}],"balance_after":23414,"source":{"system":"sec-edgar","filing":"0001437749-24-003155","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003155/rdgdoc.xml","form_type":"4/A","original_submission_date":"2024-02-02"}},{"id":1658916,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-06T02:16:49.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":1248,"price":15.78,"value":19693.44,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024."}],"balance_after":20076,"source":{"system":"sec-edgar","filing":"0001437749-24-003155","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003155/rdgdoc.xml","form_type":"4/A","original_submission_date":"2024-02-02"}},{"id":1658915,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-06T02:16:49.000Z","date":"2024-02-01","kind":"sale","planned":false,"acquired":false,"shares":417,"price":15.78,"value":6580.26,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024."}],"balance_after":18824,"source":{"system":"sec-edgar","filing":"0001437749-24-003155","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003155/rdgdoc.xml","form_type":"4/A","original_submission_date":"2024-02-02"}},{"id":1661728,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027."}],"balance_after":16500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661727,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024."}],"balance_after":13334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661726,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."}],"balance_after":2500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661725,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":834},"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661724,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"sale","planned":false,"acquired":false,"shares":3328,"price":15.74,"value":52382.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":23414,"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661723,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":6666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":26742,"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661722,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"sale","planned":false,"acquired":false,"shares":1248,"price":15.74,"value":19643.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":20076,"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661721,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":21324,"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661720,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"sale","planned":false,"acquired":false,"shares":417,"price":15.74,"value":6563.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":18824,"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1661719,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2024-02-03T00:12:24.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":19241,"source":{"system":"sec-edgar","filing":"0001437749-24-003018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774924003018/rdgdoc.xml","form_type":"4"}},{"id":1784651,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-09-08T19:41:21.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the shares underlying the restricted stock units will vest on each of September 7, 2024, September 7, 2025 and September 7, 2026"}],"balance_after":10000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-23-025479","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923025479/rdgdoc.xml","form_type":"4"}},{"id":1789228,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-09-05T20:28:18.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":false,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vested in three equal installments on November 30, 2021, August 31, 2022 and August 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vested in three equal installments on November 30, 2021, August 31, 2022 and August 31, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001437749-23-025204","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923025204/rdgdoc.xml","form_type":"4"}},{"id":1789227,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-09-05T20:28:18.000Z","date":"2023-08-31","kind":"sale","planned":false,"acquired":false,"shares":3800,"price":18.01,"value":68438.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":18407,"source":{"system":"sec-edgar","filing":"0001437749-23-025204","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923025204/rdgdoc.xml","form_type":"4"}},{"id":1789226,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-09-05T20:28:18.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":true,"shares":8334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":22207,"source":{"system":"sec-edgar","filing":"0001437749-23-025204","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923025204/rdgdoc.xml","form_type":"4"}},{"id":2036140,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the shares underlying the stock options will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."}],"balance_after":40000,"derivative":{"exercise_price":10.39,"expiration_date":"2033-01-31","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2036139,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2024, January 31, 2025 and January 31, 2026."}],"balance_after":20000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2036138,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023."}],"balance_after":5000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2036137,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022."}],"balance_after":834,"derivative":{"underlying":"Ordinary Shares","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2036136,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":1227,"price":10.12,"value":12417.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":13873,"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2036135,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":2500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":15100,"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2036134,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":409,"price":10.12,"value":4139.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units."}],"balance_after":12600,"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2036133,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-02-02T18:04:04.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":13009,"source":{"system":"sec-edgar","filing":"0001437749-23-002338","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774923002338/rdgdoc.xml","form_type":"4"}},{"id":2167621,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-09-02T15:40:01.000Z","date":"2022-08-31","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vest in three equal annual installments on November 30, 2021, August 31, 2022 and August 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on August 31, 2020 representing 25,000 ordinary shares. The RSUs vest in three equal annual installments on November 30, 2021, August 31, 2022 and August 31, 2023."}],"balance_after":8334,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001437749-22-021776","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774922021776/rdgdoc.xml","form_type":"4"}},{"id":2167620,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-09-02T15:40:01.000Z","date":"2022-08-31","kind":"sale","acquired":false,"shares":3606,"price":7.21,"value":25999.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units"}],"balance_after":12176,"source":{"system":"sec-edgar","filing":"0001437749-22-021776","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774922021776/rdgdoc.xml","form_type":"4"}},{"id":2167619,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-09-02T15:40:01.000Z","date":"2022-08-31","kind":"exercise","acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":15782,"source":{"system":"sec-edgar","filing":"0001437749-22-021776","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000143774922021776/rdgdoc.xml","form_type":"4"}},{"id":2416705,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T21:35:21.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025."}],"balance_after":30000,"derivative":{"exercise_price":7.72,"expiration_date":"2032-01-31","underlying":"Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-006387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006387/doc4.xml","form_type":"4"}},{"id":2416704,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-02-02T21:35:21.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025."}],"balance_after":7500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-22-006387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006387/doc4.xml","form_type":"4"}},{"id":2416703,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-02-02T21:35:21.000Z","date":"2022-01-31","kind":"exercise","acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reporting person was granted RSUs on January 31, 2021 representing 2,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022."}],"balance_after":1667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001209191-22-006387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006387/doc4.xml","form_type":"4"}},{"id":2416702,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-02-02T21:35:21.000Z","date":"2022-01-31","kind":"sale","acquired":false,"shares":414,"price":7.58,"value":3138.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units"}],"balance_after":7449,"source":{"system":"sec-edgar","filing":"0001209191-22-006387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006387/doc4.xml","form_type":"4"}},{"id":2416701,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-02-02T21:35:21.000Z","date":"2022-01-31","kind":"exercise","acquired":true,"shares":833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":7863,"source":{"system":"sec-edgar","filing":"0001209191-22-006387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919122006387/doc4.xml","form_type":"4"}},{"id":2488766,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-12-02T18:16:10.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of November 30, 2021, August 31, 2022 and August 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of November 30, 2021, August 31, 2022 and August 31, 2023."}],"balance_after":16667,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001209191-21-067440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121067440/doc4.xml","form_type":"4"}},{"id":2488765,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-12-02T18:16:10.000Z","date":"2021-11-30","kind":"sale","acquired":false,"shares":3803,"price":12.03,"value":45750.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units"}],"balance_after":7030,"source":{"system":"sec-edgar","filing":"0001209191-21-067440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121067440/doc4.xml","form_type":"4"}},{"id":2488764,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2021-12-02T18:16:10.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer"}],"balance_after":10833,"source":{"system":"sec-edgar","filing":"0001209191-21-067440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121067440/doc4.xml","form_type":"4"}},{"id":2677606,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-08T18:33:56.000Z","date":"2021-06-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares underlying the stock options will vest on each of June 1, 2022, June 1, 2023 and June 1, 2024."}],"balance_after":15000,"derivative":{"exercise_price":17.98,"expiration_date":"2031-05-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-038842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121038842/doc4.xml","form_type":"4"}},{"id":2708153,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-05-18T15:35:11.000Z","date":"2021-05-17","kind":"purchase","acquired":true,"shares":2500,"price":15.71,"value":39275.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $15.675\nand 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-21-033399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121033399/doc4.xml","form_type":"4"}},{"id":2885718,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-02-02T20:55:41.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024."}],"balance_after":2500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-006709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121006709/doc4.xml","form_type":"4"}},{"id":2885717,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-02T20:55:41.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares underlying the stock option will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024."}],"balance_after":8000,"derivative":{"exercise_price":22.07,"expiration_date":"2031-01-30","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-21-006709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919121006709/doc4.xml","form_type":"4"}},{"id":3013347,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2020-10-05T20:35:24.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"date","element":"transactionDate","label":"F1","text":"The stock options and restricted stock units represented on the original Form 4 were not granted to the reporting person until October 1, 2020, following approval by the Issuer's Compensation Committee on that date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares underlying the restricted stock units will vest on each of August 31, 2021, August 31, 2022 and August 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the shares underlying the restricted stock units will vest on each of August 31, 2021, August 31, 2022 and August 31, 2023."}],"balance_after":25000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-053632","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120053632/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-10"}},{"id":3013346,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-05T20:35:24.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The stock options and restricted stock units represented on the original Form 4 were not granted to the reporting person until October 1, 2020, following approval by the Issuer's Compensation Committee on that date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the shares underlying the stock option will vest on each of August 31, 2021, August 31, 2022 and August 31, 2023."}],"balance_after":60000,"derivative":{"exercise_price":19.66,"expiration_date":"2030-09-30","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-053632","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120053632/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-10"}},{"id":3034416,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2020-09-10T16:14:52.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the restricted stock units (\"RSUs\") will vest on September 9, 2021,  33.33% of the remaining RSUs will vest on September 9, 2022, and 33.34% of the remaining RSUs will vest on September 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"33.33% of the restricted stock units (\"RSUs\") will vest on September 9, 2021,  33.33% of the remaining RSUs will vest on September 9, 2022, and 33.34% of the remaining RSUs will vest on September 9, 2023."}],"balance_after":25000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-049937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120049937/doc4.xml","form_type":"4"}},{"id":3034415,"issuer":{"id":4466,"kind":"organization","name":"UroGen Pharma Ltd.","symbol":"URGN"},"owners":[{"id":66892,"kind":"person","name":"Smith Jason Drew","position":1,"cik":"0001821479","reported_name":"Smith Jason Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-09-10T16:14:52.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.33% of the shares underlying the stock option will vest on September 9, 2021, 33.33% of the remaining shares underlying the stock option will vest on September 9, 2022, and 33.34% of the remaining shares shares underlying the stock option will vest on September 9, 2023."}],"balance_after":60000,"derivative":{"exercise_price":21.38,"expiration_date":"2030-09-08","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-049937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668243/000120919120049937/doc4.xml","form_type":"4"}}]}